CAMBRIDGE, Mass.--(BUSINESS WIRE)--Universal DX (“UDX”), a biotech company dedicated to transforming cancer into a curable disease by detecting it early, today announced closure of the Series B which ...
-- SIGNAL-AA Part B exceeded target enrollment based on demand from patients; trial size increased to 33 patients -- WALTHAM, Mass., Oct. 21, 2025 /PRNewswire/ -- Q32 Bio Inc. (NASDAQ: QTTB) ("Q32 Bio ...
Nishit Agarwal exemplifies excellence in Biomedical AI and Signal Processing with extensive experience in developing cutting-edge clinical AI solutions and biomarker development. His expertise spans ...
Clinical trials are considered the cornerstone of health care research because they provide the most reliable and scientifically rigorous method for evaluating new medical interventions.
Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, today announced the launch of its first ultrasensitive multiplexed digital PCR assay, the ddPLEX ...
Mercy BioAnalytics, Inc., a pioneer in blood-based detection of early-stage cancer, today announced data from a ...
Hosted on MSN
Clinical trial significantly improves detection of hidden blood clots in stroke patients
A clinical trial led by London Health Sciences Centre Research Institute (LHSCRI) and Western University's Schulich School of Medicine & Dentistry may enhance how medical professionals detect hidden ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback